Developer docs
API playgroundTry for free, no card

Search company profiles

Wellinks

Full company profile

uuid0006vdy

Namestring
Wellinks
Legal namestring
Convexity Scientific Inc.
Websiteurl
wellinks.com
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Wellinks (legal entity Convexity Scientific Inc.) is a US digital health company focused on virtual-first management of chronic obstructive pulmonary disease (COPD). It operates a platform that combines the Spire RPM System — a continuous cardiorespiratory remote patient monitoring stack built around a wearable respiratory sensor (Spire Health Tag) and a cellular Home Hub — with AI-driven Predictive Patient Care and a virtual pulmonary rehabilitation program delivered by a multidisciplinary clinical team. The Spire Health business was acquired in September 2024 in a non-cash transaction, and the pulmonary rehabilitation program was acquired from Sparo in June 2022.

The company's commercial model is enterprise B2B: it sells outcomes-oriented, value-based care contracts to Medicare Advantage plans, Managed Medicaid, commercial insurers, and risk-bearing provider networks, with claimed 3X ROI, $11.3k average annual savings per patient, 65% reduction in hospitalizations, and 45% fewer ER visits. Distribution is through direct field sales into named partners including Highmark Blue Cross Blue Shield Delaware, UMass Memorial Health, Hartford HealthCare, SoNE HEALTH, and CareAbout Health, with geographic concentration in the Northeast plus new footprints in New Jersey and Florida. Revenue is recurring via subscription-style value-based contracts, services are provided at no direct cost to eligible patients, and pricing is not publicly disclosed.

Wellinks is privately held, headquartered in New Haven, Connecticut, backed by venture investors including Morningside, HighCape Capital, Connecticut Innovations, and Benslie, and holds SOC 2 Type 2 and HIPAA compliance. Leadership includes CEO Stacie Bratcher (appointed July 2023), CSO Dr. Abi Sundaramoorthy (formerly CMO), and board member Douglas Wenners.

Short descriptiontext

Wellinks is a US digital health company that delivers virtual-first COPD management — combining Spire Health remote patient monitoring, AI-driven predictive analytics, and virtual pulmonary rehabilitation — through value-based care contracts with Medicare Advantage plans, health systems, and risk-bearing provider networks.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNew Haven, United States
HQ citystring
New Haven
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
virtual pulmonary rehabilitation, remote patient monitoring, COPD management platform, predictive patient analytics, chronic disease management
Industry4 codes
PRIMARYHLALAFAB
Respiratory & Sleep RPM (COPD, asthma, sleep apnea)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLACAGAG
Chronic Disease Management Pathways (e.g., diabetes, CHF, COPD)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools
SECONDARYHLADAJAK
Pulmonary Rehabilitation Programs
Healthcare & Life Sciences/Elder Care & Long-Term Care/Rehabilitation & Post-Acute Care Centers (Inpatient/Outpatient)
SECONDARYHLAFAEAF
Home Respiratory & Sleep Therapy Providers (DME-Integrated)
NAICS code1 code
  • Offices of Physicians6211
SIC code3 codes
  • Services-Home Health Care Services8082
  • Services-Health Services8000
  • Surgical & Medical Instruments & Apparatus3841
Product category
Digital Health / Remote Patient Monitoring
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Value-Based Care Contracts
TypeSubscription Recurring
Description

Wellinks generates revenue through value-based care agreements with health plans and providers, where compensation is tied to measurable outcomes including reductions in hospital admissions, ER visits, and total cost of care. The company demonstrates 3X ROI to payer partners.

wellinks.com
2Remote Patient Monitoring Services
TypeSubscription Recurring
Description

RPM monitoring services billed to payers for continuous cardiorespiratory monitoring of COPD patients. Includes Spire device provision, clinical decision support, and care team coordination.

wellinks.com
3Virtual Pulmonary Rehabilitation
TypeSubscription Recurring
Description

Virtual pulmonary rehabilitation sessions and programs delivered to patients, billed through value-based care arrangements or fee-for-service RPM codes. Includes coaching, clinical support, and educational resources.

wellinks.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Pricing details1 tier
1Value-Based Care Partnership Model
ModelSubscriptionBilling cadenceAnnual
Notes

B2B subscription model through health plan and provider partnerships. ROI-based pricing tied to measurable clinical outcomes and cost savings. No direct-to-consumer pricing publicly disclosed.

wellinks.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1Spire RPM System
Description

Remote patient monitoring system with continuous cardiopulmonary monitoring, predictive analytics, and clinical decision support for COPD and cardiopulmonary care.

wellinks.com
+2 more records
Core offering1 text field

Wellinks provides a virtual-first integrated COPD management platform combining continuous remote patient monitoring via Spire Health wearable sensor technology, AI-powered predictive analytics, and virtual pulmonary rehabilitation services. The platform captures 2,000-4,000 breaths per day through the Spire Health Tag and uses predictive modeling to detect deviations from patient baselines, enabling early clinical intervention. The offering is delivered to health plans, Medicare Advantage plans, Managed Medicaid, health systems, and value-based care providers under value-based care contracts.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 45% fewer COPD-related ER visits
+5 more records
Product overview1 text field

Wellinks is a digital healthcare company offering a virtual-first COPD management platform. The core offering consists of the Spire RPM System (acquired from Spire Health in September 2024), which provides continuous cardiopulmonary monitoring through the Spire Health Tag wearable sensor and Spire Home Hub. Built on this remote monitoring foundation is the Predictive Patient Care model, which uses AI-powered analytics to detect health deviations and enable early intervention. The platform also includes Virtual Pulmonary Rehabilitation, providing patients with virtual coaching, clinical support, and educational resources. The Spire RPM System collects 2K-4K breaths per day along with pulse rate, activity, and sleep data, while the Predictive Patient Care model analyzes this data to identify deviations from patient baselines and trigger proactive clinical outreach.

Product and service3 records
1Spire RPM System
CategoryRemote Patient Monitoring
Description

Remote patient monitoring platform that integrates continuous cardiopulmonary monitoring, advanced data algorithms, and clinical decision support for COPD and cardiopulmonary care. The system captures 2,000-4,000 breaths per day along with pulse rate, activity, and sleep data, and includes the Spire Health Tag wearable sensor and cellular Home Hub for automatic data sync. Designed for health plans, Medicare Advantage, Managed Medicaid, and value-based care providers managing COPD populations.

2Predictive Patient Care
CategoryPredictive Analytics Software
Description

AI-powered care model that uses predictive analytics and real-time continuous patient monitoring data to detect deviations from patient respiratory baselines, enabling early intervention before symptoms escalate. Reduces hospitalizations and improves cardiopulmonary outcomes through proactive clinical outreach. Built on the Spire RPM System data foundation and delivered to health plans and value-based care providers.

3Virtual Pulmonary Rehabilitation
CategoryVirtual Care Services
Description

Virtual pulmonary rehabilitation program providing remote COPD management through virtual coaching, personalized one-on-one clinical coaching with certified health coaches, asthma educators, physicians, registered nurses, respiratory therapists, and clinical exercise physiologists, plus educational resources for patients with chronic respiratory diseases. Includes 24/7 nurse triage support and is delivered to health plan and provider partners' member populations.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-03-01
Description

Partnership to expand virtual-first COPD management programs within value-based care networks. The collaboration aims to improve patient outcomes and reduce hospitalization rates in New Jersey and Florida markets. CareAbout Health provides access to value-based care network infrastructure.

2SoNE HEALTH
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-09-29
Description

Collaboration to deliver high quality COPD care to patients in the SoNE HEALTH network. Southern New England Healthcare is a regional leader in value-based care and population health management. The partnership connects COPD patients with Wellinks' virtual pulmonary care services.

wellinks.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-08-08
Description

Integration of Wellinks' virtual pulmonary rehabilitation program at UMass Memorial Health to support COPD patients in Central Massachusetts. Collaboration with UMMH's Center for Digital Health Solutions and Digital Health Clinic. Builds on ongoing Healthy at Home study with UMass Chan Medical School.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-06-28
Description

Agreement to deliver high-quality COPD care to underserved populations in Delaware starting July 1, 2023. Partnership aims to reduce access barriers for members with COPD by offering virtual pulmonary rehabilitation care.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

Multi-year research collaboration including the Healthy at Home study assessing feasibility of app-based consumer technology and comprehensive virtual disease management. Principal investigator Dr. Apurv Soni leading Program in Digital Medicine research partnership.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

ASPIRE clinical trial collaboration to assess impact of Wellinks on quality of life, engagement, and satisfaction among COPD Foundation members. Patient survey conducted to measure program effectiveness and outcomes.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

POWER study partnership to evaluate impact of Wellinks' COPD management program on hospital readmissions for COPD patients. Clinical research collaboration to measure program effectiveness.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

RPM platform owned by Optum (UnitedHealth Group) serving chronic and post-acute populations. Comparable RPM technology stack and enterprise health plan distribution, though part of a much broader portfolio.

TypeDirect peer
Description

Virtual chronic condition management platform combining coaching, mental health, and remote monitoring for diabetes, hypertension, and musculoskeletal conditions. Comparable enterprise health plan GTM and value-based outcomes focus.

TypeDirect peer
Description

Virtual-first chronic disease management company delivering behavior-change programs for diabetes, hypertension, and musculoskeletal conditions. Comparable as a virtual chronic care platform reimbursed via value-based contracts with payers and employers.

TypeDirect peer
Description

AI-driven chronic disease coaching platform for diabetes, hypertension, and prediabetes delivered via mobile app with continuous monitoring. Comparable virtual-first chronic care delivery with health plan partnerships.

TypeDirect peer
Description

Virtual rehabilitation platform for musculoskeletal conditions combining wearable sensors, AI coaching, and remote physical therapists. Comparable care delivery model (virtual rehab + RPM + clinical coaching) and payer contracting motion.

TypeEmerging player
Description

Digital therapeutics company with programs for musculoskeletal pain and COPD pulmonary rehabilitation. Directly overlaps with Wellinks' virtual pulmonary rehabilitation offering for COPD patients.

7Health Recovery Solutions
TypeDirect peer
Description

RPM platform for chronic care management including COPD, CHF, and hypertension delivered to health systems and payers. Comparable enterprise RPM business model and condition focus.

TypeDirect peer
Description

Digital respiratory health platform acquired by ResMed; offers connected inhalers and COPD/asthma management software. Most directly comparable peer given overlapping COPD patient population and remote monitoring approach.

9Biofourmis
TypeBroad incumbent
Description

Hospital-at-home and RPM platform with AI-driven predictive analytics for cardiac, respiratory, and oncology patients. Comparable on the predictive RPM + AI analytics axis with a broader condition portfolio.

TypeEmerging player
Description

Cloud-based platform for sleep and respiratory diagnostics and care management serving health systems and durable medical equipment providers. Adjacent in respiratory/sleep digital health.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Wellinks

Digital Health / Remote Patient Monitoringwellinks.com

Wellinks is a US digital health company that delivers virtual-first COPD management — combining Spire Health remote patient monitoring, AI-driven predictive analytics, and virtual pulmonary rehabilitation — through value-based care contracts with Medicare Advantage plans, health systems, and risk-bearing provider networks.

What Wellinks does

Wellinks (legal entity Convexity Scientific Inc.) is a US digital health company focused on virtual-first management of chronic obstructive pulmonary disease (COPD). It operates a platform that combines the Spire RPM System — a continuous cardiorespiratory remote patient monitoring stack built around a wearable respiratory sensor (Spire Health Tag) and a cellular Home Hub — with AI-driven Predictive Patient Care and a virtual pulmonary rehabilitation program delivered by a multidisciplinary clinical team. The Spire Health business was acquired in September 2024 in a non-cash transaction, and the pulmonary rehabilitation program was acquired from Sparo in June 2022.

The company's commercial model is enterprise B2B: it sells outcomes-oriented, value-based care contracts to Medicare Advantage plans, Managed Medicaid, commercial insurers, and risk-bearing provider networks, with claimed 3X ROI, $11.3k average annual savings per patient, 65% reduction in hospitalizations, and 45% fewer ER visits. Distribution is through direct field sales into named partners including Highmark Blue Cross Blue Shield Delaware, UMass Memorial Health, Hartford HealthCare, SoNE HEALTH, and CareAbout Health, with geographic concentration in the Northeast plus new footprints in New Jersey and Florida. Revenue is recurring via subscription-style value-based contracts, services are provided at no direct cost to eligible patients, and pricing is not publicly disclosed.

Wellinks is privately held, headquartered in New Haven, Connecticut, backed by venture investors including Morningside, HighCape Capital, Connecticut Innovations, and Benslie, and holds SOC 2 Type 2 and HIPAA compliance. Leadership includes CEO Stacie Bratcher (appointed July 2023), CSO Dr. Abi Sundaramoorthy (formerly CMO), and board member Douglas Wenners.

Wellinks firmographics

Firmographics
Name
Wellinks
Legal name
Convexity Scientific Inc.
Website
https://wellinks.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
11–50 employees
Short description
Wellinks is a US digital health company that delivers virtual-first COPD management — combining Spire Health remote patient monitoring, AI-driven predictive analytics, and virtual pulmonary rehabilitation — through value-based care contracts with Medicare Advantage plans, health systems, and risk-bearing provider networks.
Ownership category
akta.pro rank

Wellinks industry classification

Industry
Product category
Digital Health / Remote Patient Monitoring
NAICS
Offices of Physicians (6211)
SIC
Services-Home Health Care Services (8082), Services-Health Services (8000), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLALAFAB
Respiratory & Sleep RPM (COPD, asthma, sleep apnea)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLACAGAG
Chronic Disease Management Pathways (e.g., diabetes, CHF, COPD)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools
SECONDARYHLADAJAK
Pulmonary Rehabilitation Programs
Healthcare & Life Sciences/Elder Care & Long-Term Care/Rehabilitation & Post-Acute Care Centers (Inpatient/Outpatient)
SECONDARYHLAFAEAF
Home Respiratory & Sleep Therapy Providers (DME-Integrated)

Keywords

  • Virtual pulmonary rehabilitation
  • Remote patient monitoring
  • COPD management platform
  • Predictive patient analytics
  • Chronic disease management

Where Wellinks is headquartered

Location

Headquarters

HQ city
New Haven
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Wellinks business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Value-Based Care Contracts: Wellinks generates revenue through value-based care agreements with health plans and providers, where compensation is tied to measurable outcomes including reductions in hospital admissions, ER visits, and total cost of care. The company demonstrates 3X ROI to payer partners.
  2. Remote Patient Monitoring Services: RPM monitoring services billed to payers for continuous cardiorespiratory monitoring of COPD patients. Includes Spire device provision, clinical decision support, and care team coordination.
  3. Virtual Pulmonary Rehabilitation: Virtual pulmonary rehabilitation sessions and programs delivered to patients, billed through value-based care arrangements or fee-for-service RPM codes. Includes coaching, clinical support, and educational resources.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualValue-Based Care Partnership Model

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Wellinks product offering

Product offering

Core offering

Wellinks provides a virtual-first integrated COPD management platform combining continuous remote patient monitoring via Spire Health wearable sensor technology, AI-powered predictive analytics, and virtual pulmonary rehabilitation services. The platform captures 2,000-4,000 breaths per day through the Spire Health Tag and uses predictive modeling to detect deviations from patient baselines, enabling early clinical intervention. The offering is delivered to health plans, Medicare Advantage plans, Managed Medicaid, health systems, and value-based care providers under value-based care contracts.

Product overview

Wellinks is a digital healthcare company offering a virtual-first COPD management platform. The core offering consists of the Spire RPM System (acquired from Spire Health in September 2024), which provides continuous cardiopulmonary monitoring through the Spire Health Tag wearable sensor and Spire Home Hub. Built on this remote monitoring foundation is the Predictive Patient Care model, which uses AI-powered analytics to detect health deviations and enable early intervention. The platform also includes Virtual Pulmonary Rehabilitation, providing patients with virtual coaching, clinical support, and educational resources. The Spire RPM System collects 2K-4K breaths per day along with pulse rate, activity, and sleep data, while the Predictive Patient Care model analyzes this data to identify deviations from patient baselines and trigger proactive clinical outreach.

Differentiator

Problem solved

Functional benefit

Brands

  • Spire RPM System: Remote patient monitoring system with continuous cardiopulmonary monitoring, predictive analytics, and clinical decision support for COPD and cardiopulmonary care.
  • Spire Health Tag
  • Predictive Patient Care

Products and services

  • Spire RPM System Remote patient monitoring platform that integrates continuous cardiopulmonary monitoring, advanced data algorithms, and clinical decision support for COPD and cardiopulmonary care. The system captures 2,000-4,000 breaths per day along with pulse rate, activity, and sleep data, and includes the Spire Health Tag wearable sensor and cellular Home Hub for automatic data sync. Designed for health plans, Medicare Advantage, Managed Medicaid, and value-based care providers managing COPD populations.
  • Predictive Patient Care AI-powered care model that uses predictive analytics and real-time continuous patient monitoring data to detect deviations from patient respiratory baselines, enabling early intervention before symptoms escalate. Reduces hospitalizations and improves cardiopulmonary outcomes through proactive clinical outreach. Built on the Spire RPM System data foundation and delivered to health plans and value-based care providers.
  • Virtual Pulmonary Rehabilitation Virtual pulmonary rehabilitation program providing remote COPD management through virtual coaching, personalized one-on-one clinical coaching with certified health coaches, asthma educators, physicians, registered nurses, respiratory therapists, and clinical exercise physiologists, plus educational resources for patients with chronic respiratory diseases. Includes 24/7 nurse triage support and is delivered to health plan and provider partners' member populations.

Quantifiable outcome

  • 45% fewer COPD-related ER visits
  • +5 more outcomes

Companies that use Wellinks

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Wellinks technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Wellinks partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core.

  • CareAbout HealthcoreStrategic or Co-development Partner · 1 March 2025Partnership to expand virtual-first COPD management programs within value-based care networks. The collaboration aims to improve patient outcomes and reduce hospitalization rates in New Jersey and Florida markets. CareAbout Health provides access to value-based care network infrastructure.
  • SoNE HEALTHcoreStrategic or Co-development Partner · 29 September 2024Collaboration to deliver high quality COPD care to patients in the SoNE HEALTH network. Southern New England Healthcare is a regional leader in value-based care and population health management. The partnership connects COPD patients with Wellinks' virtual pulmonary care services.
  • UMass Memorial HealthcoreStrategic or Co-development Partner · 8 August 2024Integration of Wellinks' virtual pulmonary rehabilitation program at UMass Memorial Health to support COPD patients in Central Massachusetts. Collaboration with UMMH's Center for Digital Health Solutions and Digital Health Clinic. Builds on ongoing Healthy at Home study with UMass Chan Medical School.
  • Highmark Blue Cross Blue Shield DelawarecoreStrategic or Co-development Partner · 28 June 2023Agreement to deliver high-quality COPD care to underserved populations in Delaware starting July 1, 2023. Partnership aims to reduce access barriers for members with COPD by offering virtual pulmonary rehabilitation care.
  • UMass Chan Medical SchoolcoreStrategic or Co-development Partner · 1 January 2022Multi-year research collaboration including the Healthy at Home study assessing feasibility of app-based consumer technology and comprehensive virtual disease management. Principal investigator Dr. Apurv Soni leading Program in Digital Medicine research partnership.
  • COPD FoundationcoreStrategic or Co-development Partner · 1 January 2022ASPIRE clinical trial collaboration to assess impact of Wellinks on quality of life, engagement, and satisfaction among COPD Foundation members. Patient survey conducted to measure program effectiveness and outcomes.
  • Hartford HealthCarecoreStrategic or Co-development Partner · 1 January 2022POWER study partnership to evaluate impact of Wellinks' COPD management program on hospital readmissions for COPD patients. Clinical research collaboration to measure program effectiveness.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Wellinks competitors and assessment

Company assessment

Broad incumbents

  • Vivify Health: RPM platform owned by Optum (UnitedHealth Group) serving chronic and post-acute populations. Comparable RPM technology stack and enterprise health plan distribution, though part of a much broader portfolio.
  • Biofourmis: Hospital-at-home and RPM platform with AI-driven predictive analytics for cardiac, respiratory, and oncology patients. Comparable on the predictive RPM + AI analytics axis with a broader condition portfolio.

Direct peers

  • Vida Health: Virtual chronic condition management platform combining coaching, mental health, and remote monitoring for diabetes, hypertension, and musculoskeletal conditions. Comparable enterprise health plan GTM and value-based outcomes focus.
  • Omada Health: Virtual-first chronic disease management company delivering behavior-change programs for diabetes, hypertension, and musculoskeletal conditions. Comparable as a virtual chronic care platform reimbursed via value-based contracts with payers and employers.
  • Lark Health: AI-driven chronic disease coaching platform for diabetes, hypertension, and prediabetes delivered via mobile app with continuous monitoring. Comparable virtual-first chronic care delivery with health plan partnerships.
  • Hinge Health: Virtual rehabilitation platform for musculoskeletal conditions combining wearable sensors, AI coaching, and remote physical therapists. Comparable care delivery model (virtual rehab + RPM + clinical coaching) and payer contracting motion.
  • Health Recovery Solutions: RPM platform for chronic care management including COPD, CHF, and hypertension delivered to health systems and payers. Comparable enterprise RPM business model and condition focus.
  • Propeller Health: Digital respiratory health platform acquired by ResMed; offers connected inhalers and COPD/asthma management software. Most directly comparable peer given overlapping COPD patient population and remote monitoring approach.

Emerging players

  • Kaia Health: Digital therapeutics company with programs for musculoskeletal pain and COPD pulmonary rehabilitation. Directly overlaps with Wellinks' virtual pulmonary rehabilitation offering for COPD patients.
  • Somnoware Healthcare: Cloud-based platform for sleep and respiratory diagnostics and care management serving health systems and durable medical equipment providers. Adjacent in respiratory/sleep digital health.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Wellinks social profiles

Digital presence

Wellinks compliance and trust

Trust signal

Compliance2 records

Wellinks financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Wellinks leadership team

Management profile

Number of profiles

Profiles3 records

Wellinks subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Wellinks funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Wellinks M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wellinks

What does Wellinks do?

Wellinks provides a virtual-first integrated COPD management platform combining continuous remote patient monitoring via Spire Health wearable sensor technology, AI-powered predictive analytics, and virtual pulmonary rehabilitation services. The platform captures 2,000-4,000 breaths per day through the Spire Health Tag and uses predictive modeling to detect deviations from patient baselines, enabling early clinical intervention. The offering is delivered to health plans, Medicare Advantage plans, Managed Medicaid, health systems, and value-based care providers under value-based care contracts.

Is Wellinks a public or private company?

Wellinks is a private company. It is classified as venture growth investor backed and is currently operating.

When was Wellinks founded?

Wellinks was founded in 2022. It employs 11 to 50 people.

Where is Wellinks based?

Wellinks is headquartered in New Haven, United States, in the North America region.

How does Wellinks make money?

Three revenue lines are on record. Value-Based Care Contracts are the primary driver. The others are remote Patient Monitoring Services and virtual Pulmonary Rehabilitation.

Who are Wellinks's main competitors?

Broad incumbents on record are Vivify Health and Biofourmis. Direct peers are Vida Health, Omada Health, Lark Health, Hinge Health, Health Recovery Solutions and Propeller Health. Emerging players are Kaia Health and Somnoware Healthcare.

Does Wellinks have an API?

No public API is recorded for Wellinks.

What industry is Wellinks in?

Wellinks's product category is Digital Health / Remote Patient Monitoring. Its primary akta.pro industry code is HLALAFAB, Respiratory & Sleep RPM (COPD, asthma, sleep apnea), with a secondary code of HLACAGAG, Chronic Disease Management Pathways (e.g., diabetes, CHF, COPD). Its NAICS code is 6211 and its SIC code is 8082.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireWellinks Appoints Andrew Agwunobi and Mike Waters to Board of Directors and Expands Management TeamWellinks appointed Andrew Agwunobi and Mike Waters to its board and named Stephanie Solich, Stephanie Willard, and Andrew Brimer to executive roles. The appointments aim to support scaling the company's virtual cardiopulmonary care model, which uses FDA-cleared remote patient monitoring.Pulse 2.0Wellinks Raises $10 Million Series B To Expand Predictive Cardiopulmonary CareWellinks closed its first Series B round, raising $10 million from UMass Memorial Health and existing investors to expand its predictive cardiopulmonary care platform. The funds will support broader deployment of its remote monitoring and virtual care technology, including expansion into underserved and rural communities.citybizWellinks Raises $10M Series B to Expand Predictive Cardiopulmonary CareWellinks, a healthcare technology company based in New Haven, Connecticut, raised $10 million in its Series B funding round, with participation from UMass Memorial Health and existing investors. The company aims to expand its remote cardiopulmonary patient monitoring platform and improve its predictive capabilities, targeting broader adoption and new conditions.BioWorldFinancings for Aug. 6, 2026On Aug. 6, 2026, biopharma and med-tech companies Glucotrack, Preveceutical, Twist, and Wellinks raised money through public or private financings. The brief lists these four companies as the ones raising funds on that date.Hartford Business JournalNew Haven-based Wellinks raises $10MWellinks, a New Haven-based digital healthcare firm, raised $10 million in a Series B round. The funding will support commercial growth and expand its FDA-cleared predictive-care technology for COPD and congestive heart failure. The company plans to use the funds to enhance its platform and treat additional cardiopulmonary conditions.YahooWellinks secures $10m for respiratory disease RPM tool’s advancementWellinks has raised $10 million in the first close of its Series B financing round, led by University of Massachusetts' Memorial Health and internal investors, to advance its Spire remote patient monitoring system for chronic respiratory disease management. The funding will support commercial expansion, extension into congestive heart failure, and broader cardiopulmonary care populations. The Spire RPM device, originally developed by Spire Health and inherited when Wellinks acquired Spire Health in September 2024, monitors patient vitals including breathing patterns and pulse rate to detect early physiologic changes associated with clinical deterioration.Medical Device NetworkWellinks secures $10m for respiratory disease RPM tool’s advancementWellinks has raised $10 million in the first close of its Series B financing round, led by the University of Massachusetts' Memorial Health and internal investors, to advance its remote patient monitoring tool for chronic respiratory disease management. The funding will support expansion of the company's Spire RPM system commercially, extend cardiopulmonary care to broader patient populations including those with congestive heart failure, and continue growing real-world clinical data. The investment builds on an existing partnership between UMMH and Wellinks that began with a 2022 study at UMass Chan on app-based consumer technology for COPD patients.FinSMEsWellinks Raises $10M in Series B FundingWellinks, a New Haven-based cardiopulmonary care platform, raised $10M in its first Series B round, with UMass Memorial Health among backers. The company will use the funds to expand its commercial footprint, advance predictive capabilities, and enter additional cardiopulmonary conditions.AijournWellinks Closed $10 Million Series B Funding from UMass Memorial Health and inside investorsWellinks, a cardiopulmonary care company, announced the first close of its Series B funding, securing $10 million from UMass Memorial Health and inside investors. The investment builds on an existing multiyear partnership with UMass Memorial Health and UMass Chan Medical School to accelerate commercial growth and expand patient access to Wellinks' FDA-cleared Spire Remote Patient Monitoring system. Wellinks plans to use the funding to expand its commercial footprint, advance predictive capabilities, and extend its care model to additional cardiopulmonary conditions including congestive heart failure.BitlyWellinks Closed $10 Million Series B Funding from UMass Memorial Health and inside investorsWellinks, a leader in cardiopulmonary care, announced the closing of a $10 million Series B funding round, with participation from UMass Memorial Health and other investors. The funding will be used to expand its commercial footprint, improve predictive care capabilities, and extend its technology to more diverse and high-risk patient populations.